Suchergebnisse - "Funt, Samuel A"

PubPharm (4)

1

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

enthalten in: Investigational new drugs | 2021

von Ashkar, R. | Feldman, D. | Adra, N. | +11

2

PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology : Concordance Among 3 Commonly Used and Commercially Available Antibodies

enthalten in: The American journal of surgical pathology | 2019

von Reis, H. | Serrette, R. | Posada, J. | +16

CommentIn: Transl Androl Urol. 2019 Dec;8(Suppl 5):S466-S468. - PMID 32042618

3

The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer

enthalten in: European urology | 2019

von van Dijk, N. | Funt, S. | Blank, C. | +3

CommentIn: Eur Urol. 2019 Mar;75(3):445-447. - PMID 30558899

4

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

enthalten in: Leukemia & lymphoma | 2018

von Pianko, M. | Funt, S. | Page, D. | +9

1
[1]